Multidrug Aerosol Delivery During Mechanical Ventilation
- PMID: 37256713
- PMCID: PMC10457632
- DOI: 10.1089/jamp.2022.0057
Multidrug Aerosol Delivery During Mechanical Ventilation
Abstract
Background: In the critically ill, pulmonary vasodilators are often provided off label to intubated patients using continuous nebulization. If additional aerosol therapies such as bronchodilators or antibiotics are needed, vasodilator therapy may be interrupted. This study assesses aerosol systems designed for simultaneous delivery of two aerosols using continuous nebulization and bolus injection without interruption or circuit disconnection. Methods: One i-AIRE dual-port breath-enhanced jet nebulizer (BEJN) or two Aerogen® Solo vibrating mesh nebulizers (VMNs) were installed on the dry side of the humidifier. VMN were stacked; one for infusion and the second for bolus drug delivery. The BEJN was powered by air at 3.5 L/min, 50 psig. Radiolabeled saline was infused at 5 and 10 mL/h with radiolabeled 3 and 6 mL bolus injections at 30 and 120 minutes, respectively. Two adult breathing patterns (duty cycle 0.13 and 0.34) were tested with an infusion time of 4 hours. Inhaled mass (IM) expressed as % of initial syringe activity (IM%/min) was monitored in real time with a ratemeter. All delivered radioaerosol was collected on a filter at the airway opening. Transients in aerosol delivery were measured by calibrated ratemeter. Results: IM%/h during continuous infusion was linear and predictable, mean ± standard deviation (SD): 2.12 ± 1.45%/h, 2.47 ± 0.863%/h for BEJN and VMN, respectively. BEJN functioned without incident. VMN continuous aerosol delivery stopped spontaneously in 3 of 8 runs (38%); bolus delivery stopped spontaneously in 3 of 16 runs (19%). Tapping restarted VMN function during continuous and bolus delivery runs. Bolus delivery IM% (mean ± SD): 20.90% ± 7.01%, 30.40% ± 11.10% for BEJN and VMN, respectively. Conclusion: Simultaneous continuous and bolus nebulization without circuit disconnection is possible for both jet and mesh technology. Monitoring of VMN devices may be necessary in case of spontaneous interruption of nebulization.
Keywords: administration; aerosols; drug delivery; inhalation; mechanical; nebulizers and vaporizers; ventilators.
Conflict of interest statement
The State University at Stony Brook holds patents in the fields of nebulizer development and inhaled drug delivery, which have been licensed to InspiRx. G.C.S. is a consultant to InspiRx and is a member of the Advisory Board; A.D.C. serves as a consultant to InspiRx, Inc.; M.M. and J.A.L. have no conflicts.
Figures





References
-
- Elnadoury O, Beattie J, Lubinsky AS. Uninterrupted continuous and intermittent nebulizer therapy in a COVID-19 patient using sequential vibratory mesh nebulizers: a case report. J Aerosol Med Pulm Drug Deliv 2020;33(6):357–360. - PubMed
-
- Hill NS, Preston IR, Roberts KE. Inhaled therapies for pulmonary hypertension. Respir Care 2015;60(6):794–805. - PubMed
-
- Torbic H, Szumita PM, Anger KE, et al. . Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients. J Crit Care 2013;28(5):844–848. - PubMed
-
- Haché M, Denault A, Bélisle S, et al. . Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery. J Thorac Cardiovasc Surg 2003;125(3):642–649. - PubMed